Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SHTDF - Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs

SHTDF - Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs

Sinopharm Group Co. Ltd.
  • Genetron Health, a Beijing-North Caroline diagnostic company, announced a city-wide early screening test for liver cancer in Wuxi city using the company's blood-based HCCscreen.
  • Sinopharm has filed for China approval of at least one of its two COVID-19 inactivated vaccines based on initial data from a global Phase III trial, according to a Bloomberg report.
  • Eluminex Biosciences, a Suzhou ophthalmic biotech startup, closed a $50 million Series A Financing from Lilly Asia Ventures, Hillhouse's GL Ventures and Quan Capital.

For further details see:

Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs
Stock Information
Company Name: Sinopharm Group Co. Ltd.
Stock Symbol: SHTDF
Market: OTC
Menu
SHTDF SHTDF Quote SHTDF Short SHTDF News SHTDF Articles SHTDF Message Board
Get SHTDF Alerts

News, Short Squeeze, Breakout and More Instantly...